Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study
| Autor: | Ramalingam, Suresh *, †, Forster, Judy *, Naret, Cynthia *, Evans, Terry *, Sulecki, Matt *, Lu, Haolan ‡, Teegarden, Paola §, Weber, Martin R. ‡, Belani, Chandra P. *, †, * |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2008 3(3):258-264 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|